Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $249
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Jack Meehan has maintained an Equal-Weight rating on Labcorp Holdings (NYSE:LH) and raised the price target from $234 to $249.
October 25, 2024 | 5:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has maintained its Equal-Weight rating on Labcorp Holdings and increased the price target from $234 to $249, indicating a positive outlook.
The increase in price target from $234 to $249 by Barclays suggests a positive outlook for Labcorp Holdings, which could lead to a short-term increase in stock price. The maintained Equal-Weight rating indicates a balanced view, but the raised target price is a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100